 |
1500IU Hyaluronic Acid Filler Injections Liporase Hyaluronidase
Product Details:
| Place of Origin: | korea |
| Brand Name: | Liporase Hyaluronidase |
| Certification: | Liporase |
| Model Number: | 1500IU |
| Document: | Product Brochure PDF |
Payment & Shipping Terms:
| Minimum Order Quantity: | 1box |
|---|---|
| Price: | 60$ |
| Packaging Details: | box |
| Delivery Time: | 4-7work days |
| Payment Terms: | L/C, D/A, D/P, T/T, Western Union |
| Supply Ability: | 10000 box per week |
|
Detail Information |
|||
| Model NO.: | Liporase Hyaluronidase | Trademark: | Liporase |
|---|---|---|---|
| Specification: | 10vial | Kewords: | Liporase Dissolve Hyaluronic Acid |
| Application: | Dissolve | Color: | White |
| Highlight: | 1500IU Hyaluronic Acid Filler Injections,Liporase Hyaluronidase Hyaluronic Acid Filler Injections |
||
Product Description
Liporase Dissolve Hyaluronic Acid Hyaluronidase Injection Lipolab
What is Hyaluronidase?
Hyaluronidase is an enzyme hat causes hydrolysis (breakdown) of hyaluronic acid. It is often referred to as a reversal agent for hyaluronic acid fillers. When the enzyme is injected it dissolves the synthetic hyaluronic acid filler, leaving your own intact. Liporase Hyaluronidase is made in Korea. It is used to dissolve hyaluronic acid based dermal fillers that have been placed incorrectly, excessively, or unevenly.
| Package | 10 vials in one box |
| Size | 4 * 3 * 8 cm |
| Volume | 1500 units / vial |
Liporase can be used to dissolve Dermal Fillers or to maximise the strength of lipodissolve injections. Liporase, also knowns as Hyaluronidase, is a tissue modifier indicated as an adjuvant in subcutaneous fluid administration for achieving hydration, to increase the dispersion and absorption of other injected drugs, and in subcutaneous urography for improving resorption of radiopaque agents.
Important Info:
- Those with hypersensitivity to hyaluronidase or any other ingredient in the formulation is not allowed to use this product
- Discontinue recombinant (hyaluronidase human injection) if sensitization occurs.
- Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs.
- Hyaluronidase should not be injected into or around an infected or acutely inflamed area because of the danger of spreading a localized infection.
- Hyaluronidase should not be used to reduce the swelling of bites or stings.
- Hyaluronidase should not be used for intravenous injections because the enzyme is rapidly inactivated.
- Furosemide, the benzodiazepines and phenytoin have been found to be incompatible with hyaluronidase.
- Anaphylactic-like reactions following retrobulbar block or intravenous injections have occurred, rarely.
- Hyaluronidase should not be applied directly to the cornea. It is not for topical use.
Indications to using the product:
- Overcorrection by fillers in contour plastics;
- Granulomas (nodular formations);
- Fibro-sclerotic form of cellulites.
Injections are made directly into the area of correction. Following the injection there starts the destruction of molecular compounds of hyaluronic acid. Shorter oligomers are injected naturally. The procedure result will be noticeable following 2 days.
Composition:
Depolymerizing enzyme hyaluronidase 1500 c.u. (activity is expressed in conditional units)
